Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Muschiol, Sandra ^a,c   Normark, Staffan ^c   Henriques Normark, Birgitta ^b,c   Subtil, Agathe ^a  

^a CNRS   (France)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ANTIINFECTIVE AGENT; INP 0341; INP 0400; PROTEIN CDC42; RAC PROTEIN; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE; HYDRAZINE DERIVATIVE;

ARTICLE; BACTERIAL GROWTH; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; HOST CELL; HUMAN; HUMAN CELL; TYPE III SECRETION SYSTEM; YERSINIA; CHLAMYDIA; CHLAMYDIASIS; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HELA CELL; METABOLISM; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIAE; YERSINIA;

ACTINS; ANTI-BACTERIAL AGENTS; CHLAMYDIA; CHLAMYDIA INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, BACTERIAL; GTP PHOSPHOHYDROLASES; HELA CELLS; HUMANS; HYDRAZINES; YERSINIA;

EID: 65549090158     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-75     Document Type: Article

References (27)

1. The type III secretion injectisome. GR Cornelis, Nat Rev Microbiol 2006 4 11 811 825 10.1038/nrmicro1526 17041629 (Pubitemid 44593948)
2. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. A Subtil C Parsot A Dautry-Varsat, Mol Microbiol 2001 39 3 792 800 10.1046/j.1365-2958.2001.02272.x 11169118 (Pubitemid 32158156)
3. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. RH Valdivia, Curr Opin Microbiol 2008 11 1 53 59 10.1016/j.mib.2008.01.003 18299248
4. Type III secretion in Chlamydia : a case of déj vu? P Bavoil R-C Hsia, Mol Microbiol 1998 28 860 862 10.1046/j.1365-2958.1998.00861.x 9643553 (Pubitemid 28234395)
5. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. KA Fields T Hackstadt, Mol Microbiol 2000 38 5 1048 1060 10.1046/j.1365-2958.2000.02212.x 11123678 (Pubitemid 32009679)
6. Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis. HJ Betts LE Twiggs MS Sal PB Wyrick KA Fields, J Bacteriol 2008 190 5 1680 1690 18165300 10.1128/JB.01671-07
7. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. KA Fields DJ Mead CA Dooley T Hackstadt, Mol Microbiol 2003 48 3 671 683 10.1046/j.1365-2958.2003.03462.x 12694613 (Pubitemid 36819054)
8. Recent insights into the mechanisms of Chlamydia entry. A Dautry-Varsat A Subtil T Hackstadt, Cellular Microbiology 2005 7 12 1714 1722 16309458 (Pubitemid 41685265)
9. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. RA Carabeo SS Grieshaber E Fischer T Hackstadt, Infect Immun 2002 70 7 3793 3803 12065523 10.1128/IAI.70.7.3793-3803. 2002 (Pubitemid 34666020)
10. Requirement for the Rac GTPage in Chlamydia trachomatis invasion of non-phagocytic cells. RA Carabeo SS Grieshaber A Hasenkrug C Dooley T Hackstadt, Traffic 2004 5 6 418 425 10.1111/j.1398-9219.2004.00184.x 15117316 (Pubitemid 38765436)
11. Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity. A Subtil B Wyplosz ME Balãá A Dautry-Varsat, J Cell Sci 2004 117 3923 3933 10.1242/jcs.01247 15265988 (Pubitemid 39207329)
12. ARF6 GTPase controls bacterial invasion by actin remodelling. ME Balãá F Niedergang A Subtil A Alcover P Chavrier A Dautry-Varsat, J Cell Sci 2005 118 10 2201 2210 10.1242/jcs.02351 15897187 (Pubitemid 40872842)
13. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. DR Clifton KA Fields NA Grieshaber CA Dooley ER Fischer DJ Mead RA Carabeo T Hackstadt, Proc Natl Acad Sci USA 2004 101 10166 10171 15199184 10.1073/pnas.0402829101 (Pubitemid 38891213)
14. Chlamydial TARP is a bacterial nucleator of actin. TJ Jewett ER Fischer DJ Mead T Hackstadt, Proc Natl Acad Sci USA 2006 103 42 15599 15604 17028176 10.1073/pnas.0603044103 (Pubitemid 44625638)
15. Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. BJ Lane C Mutchler S Al Khodor SS Grieshaber RA Carabeo, PLoS Pathog 2008 4 3 e1000014 18383626 10.1371/journal.ppat.1000014
16. Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases. TJ Jewett CA Dooley DJ Mead T Hackstadt, Biochem Biophys Res Commun 2008 371 2 339 344 10.1016/j.bbrc.2008.04.089 18442471
17. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. S Muschiol L Bailey A Gylfe C Sundin K Hultenby S Bergstrom M Elofsson H Wolf-Watz S Normark B Henriques-Normark, Proc Natl Acad Sci USA 2006 103 39 14566 14571 16973741 10.1073/pnas.0606412103 (Pubitemid 44484790)
18. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. K Wolf HJ Betts B Chellas-Gery S Hower CN Linton KA Fields, Mol Microbiol 2006 61 6 1543 1555 16968227 10.1111/j.1365-2958.2006.05347.x (Pubitemid 44359382)
19. Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. A Slepenkin PA Enquist U Hagglund LM de la Maza M Elofsson EM Peterson, Infect Immun 2007 75 7 3478 3489 17470544 10.1128/IAI.00023-07 (Pubitemid 47040949)
20. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. L Bailey A Gylfe C Sundin S Muschiol M Elofsson P Nordstrom B Henriques-Normark R Lugert A Waldenstrom H Wolf-Watz, FEBS Lett 2007 581 4 587 595 10.1016/j.febslet.2007.01.013 17257594 (Pubitemid 46223561)
21. Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. MA Scidmore DD Rockey ER Fischer RA Heinzen T Hackstadt, Infect Immun 1996 64 5366 5372 8945589 (Pubitemid 26404004)
22. Small-molecule inhibitors specifically targeting type III secretion. R Nordfelth AM Kauppi HA Norberg H Wolf-Watz M Elofsson, Infect Immun 2005 73 5 3104 3114 15845518 10.1128/IAI.73.5.3104-3114.2005 (Pubitemid 40570380)
23. The Chlamydia pneumoniae type III secretion-related lcrH gene clusters are developmentally expressed operons. SP Ouellette YM Abdelrahman RJ Belland GI Byrne, J Bacteriol 2005 187 22 7853 7856 16267309 10.1128/JB.187.22.7853-7856. 2005 (Pubitemid 41587722)
24. Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton. AK Veenendaal C Sundin AJ Blocker, J Bacteriol 2009 191 2 563 570 10.1128/JB.01004-08 18996990
25. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. DD Rockey RA Heinzen T Hackstadt, Mol Microbiol 1995 15 617 626 10.1111/j.1365-2958.1995. tb02371.x 7783634
26. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. MA Scidmore-Carlson EI Shaw CA Dooley ER Fischer T Hackstadt, Mol Microbiol 1999 33 753 765 10.1046/j.1365-2958.1999.01523.x 10447885 (Pubitemid 29392656)
27. Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium. A Negrea E Bjur SE Ygberg M Elofsson H Wolf-Watz M Rhen, Antimicrob Agents Chemother 2007 51 8 2867 2876 17548496 10.1128/AAC.00223-07 (Pubitemid 47206224)